Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug

Go back to Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug
(NASDAQ: QNRX) Delayed: 4.58 +0.21 (4.81%)
Previous Close $4.37    52 Week High
Open $4.40    52 Week Low
Day High $4.70    P/E N/A 
Day Low $4.33    EPS
Volume 25,949